Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study offers insights into treatment of FIP
cat
FIP is usually found in young cats that are less than three years old.
Researchers successfully treat cats in late stage of the disease

US vets have successfully managed to treat laboratory cats suffering from the advanced stage of feline infectious peritonitis (FIP), a previously 100 per cent fatal disease.

In a study published in the journal PLOS Pathogens, researchers from Kansas State University describe their success with an antiviral treatment that stops the virus replicating.

When treatment was started at a late stage of disease, the researchers found that the cats returned to normal health within 20 days or less.

FIP is usually found in young cats that are less than three years old. Caused by coronavirus infection, most cats do not develop any symptoms at all. Yet, a small percentage of cats do go on to develop FIP.

FIP occurs in two forms: wet or dry. The wet form is more common and can be characterised by an accumulation of fluids in the abdominal area or chest cavity.

Symptoms may include fever, jaundice, and weight loss. Once set in it can progress rapidly, resulting in death or euthanasia.

Because of the rapid progression of the disease, it has not been known whether antiviral drug treatment can be effective at reversing disease progression in an infected cat.

"This is the first time we showed experimental evidence of successful treatment of laboratory cats at an advanced clinical stage of FIP," said Yunjeong Kim, an associate professor in the college’s diagnostic medicine pathobiology department.

"The knowledge gained from this study is a step forward to understanding the pathogenesis of FIP and other coronavirus infections important in humans and animals.”

Dr Kim says that the next step will be to find out how effective the antiviral treatment is for cats with naturally acquired FIP.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.